HomeOpen Access NewsPharmaceutical Industry

Pharmaceutical Industry

UK Government and CPE agree on record funding deal to expand pharmacy services

Patients will benefit from new pharmacy services, as the Government and Community Pharmacy England (CPE) agree on a £617m investment.

CBD oil for pain: What the research shows

Oils by Simpson of 2012 supplies organic full-spectrum CBD cannabis oil products. CBD oil is popular and commonly used for its potent therapeutic benefits, but what about its effect on pain? Here’s what the research shows.

MHRA approves Pfizer vaccine for 12-15-year-olds

The Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the Pfizer/BioNTech COVID-19 vaccine is safe to use in 12-15-year-olds.

Canvassing public awareness on veterinary medicines

Roxane Feller, Secretary General of AnimalhealthEurope, explains to us canvassing public awareness on the benefits of veterinary medicines.

Commission signs third contract for 1.8 billion BioNTech-Pfizer doses

The European Commission has announced that it has signed a third contract to secure an additional 1.8 billion BioNTech-Pfizer vaccine doses.

Logistics & supply chain will win the COVID-19 war

Professor Richard Wilding argues that biochemistry is winning the battle against coronavirus, but logistics and supply chain will win the war.

EU4Health: Building healthcare systems of tomorrow

European Commission Director General for Health and Food Safety Sandra Gallina details the ambitious EU4Health Programme proposed as a response to COVID-19.

Will 2021 see the UK’s cannabis industry bloom?

John Binns & David Hardstaff from BCL Solicitors LLP, reveal if 2021 will be the year that sees the UK’s cannabis industry bloom.

Benchmarking Regulatory systems governing veterinary medicines – part 2

Rick Clayton, Technical Director, AnimalhealthEurope, in the second chapter of this three-part series, continues to examine Benchmarking Regulatory systems governing veterinary medicines.

Building readiness for innovative health technologies

Senior Researcher in Social Science Michael Morrison explains why disruptive technologies need institutional and systemic readiness to truly realise the benefits of healthcare innovation.

Why COVID vaccine development was exceptionally speedy

Ram May-Ron, Managing Partner at FreeMind Group, explains why COVID vaccine development was exceptionally speedy.

COVID-19 vaccine does not damage placentas

Researchers from Northwestern Medicine have studied the placentas from patients who received the COVID-19 vaccine during pregnancy and found no evidence of damage.

Immune system research: Vaccines and immunotherapeutics

Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.

The stress of making diabetes decisions

Cyndi Williams, Co-Founder and CEO of Quin, explores the stress of making diabetes decisions when it comes to injecting insulin.

Under 40s will be offered an alternative to the Astrazeneca vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that all under 40s should be offered an alternative to the Oxford/AstraZeneca vaccine following blood clot risk.

Countries denied access to vaccines they helped develop

A new study has revealed that new medicines and vaccines approved for use in the United States are often unavailable in countries that helped to develop them.

COVID-19 variant vaccines will be fast-tracked through cutting-edge testing centre

Health Secretary Matt Hancock has announced that vaccines tailored to tackle COVID-19 variants will be fast-tracked through new state-of-the-art labs.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders